Evidence-based Evaluation of TCM Key Syndrome Differentiation and Treatment for Acute Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

Also called NCT04199455

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04199455
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04199455. Randomized; double masking; primary purpose treatment. Start 2019-12-04 (actual); primary completion 2021-05-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evidence-based Evaluation of TCM Key Syndrome Differentiation and Treatment for Acute Ischemic Stroke
Intervention (Drug)
Integrative Treatment (EPACH Recipe Granules + NQABC Recipe Granules)
Intervention (Drug)
Placebo
Lead sponsor
Guangzhou University of Traditional Chinese Medicine (class: other)

Record details

Record id
cardio:ct-nct04199455
Content hash
d93a53124fca1d65a6cb44edc69d7110cdae10a828ae716479870229df18eac4